Next Article in Journal
Graft Polymers Derived from Pharmaceutically Active Choline-Based Ionic Liquid Monomers: Dual Incorporation of Ampicillin and Cloxacillin
Previous Article in Journal
Distinct Intrinsic and Extrinsic Factors Differentially Regulate Skeletal Stem Cells in Calvaria Versus Long Bones During Bone Regeneration
Previous Article in Special Issue
Natural Biomolecules and Light: Antimicrobial Photodynamic Strategies in the Fight Against Antibiotic Resistance
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Photodynamic Antibacterial Potential of New Tetracationic Zinc(II) Phthalocyanines Bearing 4-((Diethylmethylammonium)methyl)phenoxy Substituents

1
Prokhorov General Physics Institute of the Russian Academy of Sciences, Moscow 119991, Russia
2
Institute of Engineering Physics for Biomedicine, National Research Nuclear University MEPhI, Moscow 115409, Russia
3
Department of Oncology, Radiotherapy and Reconstructive Surgery, Levshin Institute of Cluster Oncology, Sechenov First Moscow State Medical University, Moscow 119435, Russia
4
Frumkin Institute of Physical Chemistry and Electrochemistry, Russian Academy of Sciences, Moscow 119071, Russia
5
Faculty of Chemistry, National Research University Higher School of Economics, Moscow 109028, Russia
6
Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, Moscow 119071, Russia
7
Faculty of Biology, Lomonosov Moscow State University, Moscow 119234, Russia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(19), 9414; https://doi.org/10.3390/ijms26199414
Submission received: 30 July 2025 / Revised: 10 September 2025 / Accepted: 17 September 2025 / Published: 26 September 2025
(This article belongs to the Special Issue New Molecular Insights into Antimicrobial Photo-Treatments)

Abstract

Photodynamic inactivation and antimicrobial photodynamic therapy (PDI/APDT) based on the toxic properties of reactive oxygen species (ROS), which are generated by a number of photoexcited dyes, are promising for preventing and treating infections, especially those associated with drug-resistant pathogens. The negatively charged bacterial cell surface attracts polycationic photosensitizers, which contribute to the vulnerability of the bacterial plasma membrane to ROS. The integrity of the plasma membrane is critical for the viability of the bacterial cell. Polycationic phthalocyanines are regarded as promising photosensitizers due to their high quantum yields of ROS generation (mainly singlet oxygen), high extinction coefficients in the far-red spectral range, and low dark toxicity. For application in PDI/APDT, the wide range of possibilities of modifying the chemical structure of phthalocyanines is particularly valuable, especially by introducing various peripheral and non-peripheral substituents into the benzene rings. Depending on the type and location of such substituents, it is possible to obtain photosensitizers with different photophysical properties, photochemical activity, solubility in an aqueous medium, biocompatibility, and tropism for certain structures of photoinactivation targets. In this study, we tested novel water-soluble Zn (II) phthalocyanines bearing four 4-((diethylmethylammonium)methyl)phenoxy substituents with symmetric and asymmetric charge distributions for photodynamic antibacterial activity and compared them with those of water-soluble octacationic zinc octakis(cholinyl)phthalocyanine. The obtained results allow us to conclude that the studied tetracationic aryloxy-substituted Zn(II) phthalocyanines effectively bind to the oppositely charged cell wall of the Gram-negative bacteria E. coli. This finding is supported by data on bacteria’s zeta potential neutralization in the presence of phthalocyanine derivatives and fluorescence microscopy images of stained bacterial cells. Asymmetric substitution influences the aggregation and fluorescent characteristics but has little effect on the ability of the studied tetracationic phthalocyanines to sensitize the bioluminescent E. coli K12 TG1 strain. Both symmetric and asymmetric aryloxy-substituted phthalocyanines are no less effective in PDI than the water-soluble zinc octakis(cholinyl)phthalocyanine, a photosensitizer with proven antibacterial activity, and have significant potential for further studies as antibacterial photosensitizers.

1. Introduction

The loss of effectiveness in the treatment of infectious diseases due to the development of antimicrobial resistance (AMR) in pathogens results in increased morbidity and mortality, prolonged hospital stays, and financial losses, representing a major public health challenge [1]. Due to the progressive growth of microbial resistance and the limited capacity to develop new antimicrobials, the number of deaths associated with resistant pathogens is predicted to increase to 10 million per year by 2050 [2]. The external structures (cell wall, capsule, exopolysaccharides) and the matrix of biofilms are the “first line” of defense of bacterial cells. Modification of the structure and changes in the physicochemical properties of the cell surface are the most important protective mechanisms that allow bacterial cells to reduce tropism and, consequently, the antibacterial activity of many compounds [3]. In Gram-negative bacteria, cells possess an additional outer asymmetric membrane, which is separated from the cytoplasmic (or plasma) membrane by a periplasmic space with a thin layer of peptidoglycan [4]. The external layer of this outer membrane is composed of tightly packed lipopolysaccharides (LPS) characterized by a high content of negatively charged groups in their core region exposed on the external cell surface. Divalent cations of Mg2+ and Ca2+ form cross-links between neighboring LPS molecules to stabilize the LPS layer. Beneath this externally charged surface of the outer membrane lies the LPS lipid A layer with saturated acyl chains [5]. The inner layers of the outer membrane and the plasma membrane are composed of phospholipids. However, unlike eukaryotic cells, bacterial plasma membranes are enriched with negatively charged phospholipids. This combination of negatively charged and uncharged layers forms an effective intrinsic permeability barrier for lipophilic and anionic hydrophilic molecules. The entry of small, up to 600 Da [6], polar hydrophilic molecules through the outer membrane occurs mainly via embedded protein channels called porins. Thus, the entry of aminoglycosides [7] with a charge from +3 to +5 by Escherichia coli cells is most likely realized through “nonspecific” porins. Organic polycations can competitively interact with divalent cations Mg2+ and Ca2+, displacing them and thereby destabilizing the outer membrane, which promotes the absorption of other molecules of the polycationic agent [8]. At the same time, for molecules of the hydrophobic cation methylene blue, the pathways of penetration through the lipid bilayer of the LPS membrane and through the porin channel are energetically equivalent [9]. Outer LPS and inner plasma membranes create a difficult-to-surpass barrier for adverse environmental factors, biocides, antibiotics, and antiseptics. Developing drugs that can penetrate both membranes of Gram-negative pathogens to reach intracellular targets is a challenge in medicinal chemistry [6].
Photodynamic inactivation (PDI) and antimicrobial photodynamic therapy (APDT) have demonstrated significant potential in the prevention and treatment of infections, particularly associated with drug-resistant pathogens [10]. The technology is based on the toxic properties of reactive oxygen species (ROS) for bacteria, with the low probability of developing resistance to photodynamic effects. ROS are formed as a result of the transfer of electrons (type I reactions) or energy (type II reactions) to molecular oxygen from photoexcited photosensitizer (PS) molecules in the triplet state. In photodynamic reactions of type I, the primary form of ROS is the superoxide anion radical, which can then react to form extremely active hydroxyl radicals. In photodynamic reactions of type II, the primary form of ROS is singlet oxygen.
Phthalocyanines (Pcs) are considered promising photosensitizers for PDI/APDT due to their high extinction coefficients in the spectral range of 670–800 nm (ε > 105 M−1cm−1), low dark toxicity, and extensive potential for tuning photophysical properties [11,12,13]. Consequently, the ability of phthalocyanine to generate ROS (mainly singlet oxygen) can be significantly affected by the cation complexing agent. In this regard, the diamagnetic cation Zn2+ is most appropriate for ensuring a high quantum yield of singlet oxygen photogeneration due to the “heavy atom effect”, which leads to enhanced S1→T1 intersystem crossing [14,15]. In addition, Zn2+ has been shown to form stable complexes with Pcs exhibiting low toxicity, and its salts are inexpensive compared to many other metals, providing the “heavy atom effect” [16].
The negatively charged bacterial cell surface is attractive to polycationic drugs [17]. Polycationic photosensitizers based on phthalocyanine derivatives, with high molecular weight, are incapable of penetrating the outer LPS membrane of Gram-negative bacteria via porin channels. However, given that the primary target of ROS is the bacterial plasma membrane [18] and the diffusion radius of singlet oxygen is comparable to the thickness of the cell wall of Gram-negative bacteria, such binding to the bacterial cell surface can be suitable for effective PDI. Notably, Gram-negative bacteria are able to modify LPS [19], resulting in a reduction in the density of negative charges on the cellular surface and weakening of the interaction with cationic drugs. When synthesizing new antibacterials, this cell surface-associated mechanism of drug resistance requires a balance between the number of positively charged groups, their size and polarity, and the distribution of charges.
Evidence suggests that photosensitizers with asymmetric charge distribution exhibit higher photoactivity than their counterparts with symmetric charge distribution [20,21]. In the present work, we describe the photodynamic antibacterial potential of novel water-soluble Zn (II) phthalocyanines bearing four 4-((diethylmethylammonium)methyl)phenoxy substituents with symmetric and asymmetric charge distribution and compare it with that of water-soluble octacationic zinc octakis(cholinyl)phthalocyanine.

2. Results and Discussion

2.1. Dye Fluorescence

Previously, we described the preparation and properties of a number of cationic Pcs, including octacationic ZnPcChol8+ [22] and tetracationic 4αZnPc4+ and 4αβZnPc4+ [23,24] with different arrangements of cationic 4-((diethylmethylammonium)methyl)phenoxy-groups (Figure 1).
In 4αZnPc4+, aryloxy substituents are symmetrically distributed at nonperipheral positions. In 4αβZnPc4+, all four aryloxy substituents are grafted to one of the benzene rings, i.e., two of them are at nonperipheral and two at peripheral positions. Nonperipheral substitution promotes a decrease in aggregation when phthalocyanine derivatives are present in aqueous solutions [25]. In [23], the photophysical and photochemical parameters of cationic Pcs were studied by dissolving these compounds in DMSO and subsequently transferring them into a PBS buffer. In DMSO, 4αZnPc4+ and 4αβZnPc4+ had high molar absorbance values of the Q-bands, indicating monomeric states of both phthalocyanine derivatives. In accordance with this, in DMSO, 4αZnPc4+ and 4αβZnPc4+ exhibited high quantum yields of singlet oxygen photogeneration, with ΦΔ values of 0.69 and 0.65, respectively, demonstrating the high photosensitization ability of both compounds. Given the limited water solubility of 4αZnPc4+ and 4αβZnPc4+, in this study, in the experiments with bacterial cells, we used stock solutions of 4αZnPc4+ and 4αβZnPc4+ in DMSO. When phthalocyanines were transferred in PBS, DMSO was present in probes in safe biocompatible concentrations [26], which were not more than 0.05%.
A comparison of the spectra presented in Figure 2 indicated that an increase in the concentration of aryloxy-substituted Zn(II) phthalocyanines results in the broadening of their main fluorescence band and a shift in their emission maximum to longer wavelengths. These effects become particularly evident at a concentration of 100 μM for 4αβZnPc4+ with an asymmetric distribution of charged groups. In the spectrum of 4αβZnPc4+ at 100 μM, the intensity of the long-wave peak in the spectral range of 760–780 nm, corresponding to the aggregate forms of 4αZnPc4+, and, accordingly, its contribution to the integrated fluorescence intensity increases significantly [27]. Symmetric non-peripheral substitution reduces the effect of aggregation on the phthalocyanine spectra [23].
The results of these studies align with the observation of fractions with different fluorescence lifetimes of 4αZnPc4+, 4αβZnPc4+, and ZnPcChol8+ in PBS or PBS with FBS 10% (v/v) (Figure 3). In PBS, the main primary fluorescence fraction had the lifetime of 2.57 and 2.29 ns for 4αZnPc4+and 4αβZnPc4+, respectively. These values coincide with the fluorescence lifetime of water-soluble ZnPcChol8+ (2.29 ns), are typical for metal Pcs [28], and reflect the presence of non-aggregated components. In PBS with FBS 10% (v/v), this fluorescence lifetime slightly increased for 4αZnPc4+, 4αβZnPc4+, and ZnPcChol8+ (2.9, 2.7, 2.8, respectively). The second fraction with a shorter lifetime (Figure 3B,C) was found in 4αβZnPc4+ solutions in PBS (0.34 ns) and in 4αβZnPc4+ (1.15 ns) and ZnPcChol8+ (1.07 ns) solutions in PBS with FBS 10% (v/v). This fraction is presumably associated with the aggregated state of the dye molecules.
In subsequent bacterial experiments, to avoid aggregation and at the same time obtain a sufficient fluorescence signal, the phthalocyanine concentration of 5 μM in PBS was used. When bacteria were added to 4αZnPc4+, 4αβZnPc4+, and ZnPcChol8+ solutions and subsequently precipitated, the sediment exhibited characteristic Pcs fluorescence (Figure 4A–C). In absolute terms, the fluorescence intensity of asymmetric 4αβZnPc4+ was extremely low, with an order of magnitude lower than that of symmetric 4αZnPc4+ (Figure 4D). In the bacterial sediment, fluorescence decreased slightly in the case of 4αZnPc4+ and increased twofold in the case of 4αβZnPc4+ (Figure 4E). Apparently, when 4αβZnPc4+ binds to bacterial membranes, its aggregates dissociate, which results in the increased fluorescence. Previously, dissociation of aggregates on the surface of bacteria was observed for cationic zinc phthalocyanines (ZnPc(Lys)n) [29]. In the presence of bacteria, the intensive fluorescence of ZnPcChol8+ was quenched (Figure 4F), and when measured in the sediment, it approximately matched that of 4αZnPc4+ and 4αβZnPc4+.

2.2. Fluorescence Microscopy Images

Fluorescence microscopy images of E. coli K12 TG1 cells incubated with or without polycationic Pcs were obtained using a scanning confocal microscope with laser excitation at 633 nm. In this work, the confocal microscope was used as a source for fluorescence excitation and as a tool for distinguishing fluorescence emitted by bacteria that were not fixed to glass from the fluorescence of Pcs in solution.
The bacterial cell emission in the Pcs-free control samples was only 1.2-fold higher than that from the surrounding medium. In the presence of symmetric 4αZnPc4+, the fluorescence contrast between bacteria and solution was 3.6 ± 1.2 (Table 1 shows data for five individual bacteria). In the presence of asymmetrically aryloxy-substituted 4αβZnPc4+, the contrast was even higher, with the fluorescent signal from the cells exceeding the signal from the surrounding medium by 7.3 ± 3.0. This indicates binding of aryloxy-substituted Pcs to the cell surface of Gram-negative bacteria E. coli K12 TG1. For a well-characterized antimicrobial photosensitizer, octacationic ZnPcChol8+ [30], which served as a comparison substance in our experiments, this parameter was 4.9 ± 2.4. ZnPcChol8+ readily binds to bacterial cells, and as we calculated for E. coli, when the binding sites on the cell surface are fully occupied, there are about a million molecules of ZnPcChol8+ present per cell [17]. Although the fluorescence of ZnPcChol8+ is quenched in the bound form, this quenching is compensated by the high local concentration of the bound fluorophore.
The fluorescence spectra of 4αZnPc4+, 4αβZnPc4+, and ZnPcChol8+ bound to bacteria were registered using the spectral resolution regime of the confocal microscope (Figure 5). The fluorescence spectra of symmetric tetra- and octacationic 4αZnPc4+ and ZnPcChol8+ typically exhibit a broad peak in the range of 696–706 nm. In the spectra of asymmetric 4αβZnPc4+, the fluorescence peak shifts to 686–696 nm. A shorter-wavelength maximum in the fluorescence spectrum of this compound was previously noted in bacterial sediment (Figure 4B).

2.3. Influence of Polycationic Phthalocyanines on Zeta Potential of Bacterial Cells

The binding of polycationic dyes to the negatively charged surface of bacterial cells can be detected by measuring changes in the electrophoretic mobility of the cells and, based on this, their zeta potential. In the buffer medium (10-fold diluted PBS with 0.01–0.02% DMSO) in control samples without the addition of phthalocyanine, the zeta potential of E. coli K12 TG1 was −37 mV. The addition of phthalocyanines at concentrations of 1 or 2 μM resulted in a concentration-dependent shift in the zeta potential towards more neutral values (Table 2). The magnitude of such shifts was significant, reaching 24.3 mV for 4αZnPc4+ and 21.3 for ZnPcChol8+ at 2 μM. The asymmetrically substituted 4αβZnPc4+ at 2 μM caused a shift of 18.2 mV. The obtained data clearly demonstrate the ability of all the studied polycationic Pcs to stain E. coli K12 TG1 cells. All three polycationic Pcs electrostatically bind to Gram-negative bacterial cells. The fact that 4αβZnPc4+, with a greater tendency to aggregate in water solutions, effectively neutralizes the surface of bacterial cells indicates the possibility of using this type of phthalocyanine derivative for the purpose of PDI.

2.4. Testing the Antibacterial Photodynamic Activity of Phthalocyanine Derivatives

Gram-negative pathogens possess a wider range of mechanisms of intrinsic and acquired resistance compared to Gram-positive pathogens, and are capable of acquiring and developing resistance to many classes of antibiotics. This renders them a priority for the development of novel methods of antimicrobial therapy [31]. The photodynamic potential of phthalocyanine derivatives against Gram-negative bacteria was studied using E. coli K12 TG1. This genetically modified strain, with a cloned complete lux operon from the luminescent soil entomopathogenic bacterium Photorhabdus luminescens ZMI, is a useful tool for screening photosensitizers for PDI/APDT [32]. The method is based on the correlation between photosensitized quenching of bioluminescence and the rate of inactivation of colony-forming units (CFU) in the test culture [33].
Aryloxy-substituted Zn(II) Pcs 4αZnPc4+ and 4αβZnPc4+ have been shown to be effective generators of ROS with quantum yields for singlet oxygen as high as 0.65–0.69 [23,24]. The destructive effect of ROS on plasma membranes, which are the primary targets of bacterial PDI, is based on the oxidation of unsaturated lipid acids, leading to a disruption of the barrier properties of the membrane with the formation of defects through which the loss of intracellular components occurs, which ultimately leads to cell death [18]. The plasma membrane is separated from the environment by a cell wall, the structure and permeability of which to photosensitizers differ between Gram-positive and Gram-negative bacteria. This determines the difference in the sensitivity of these two groups of bacteria to PDI [34]. Anionic photosensitizers demonstrate adequate efficacy in photodynamic inactivation of Gram-positive bacteria, but their efficiency is suboptimal for Gram-negative and mixed microbiota. Polycationic photosensitizers are quite effective against both types of bacteria and their biofilms. Indeed, both 4αZnPc4+ and 4αβZnPc4+ induced inhibition of E. coli K12 TG1 (luxABCDE) bioluminescence (Figure 6). Notably, 4αZnPc4+ and 4αβZnPc4+ exhibited comparable efficacy in PDI to the water-soluble monomeric ZnPcChol8+, a photosensitizer with proven antibacterial activity.

3. Materials and Methods

3.1. Phthalocyanine Derivatives

Long-wavelength aryloxy-substituted tetracationic phthalocyanines (Figure 1) with excitation in the spectral range of 680–690 nm were used in the study: a symmetric non-peripheral substituted 4αZnPc4+—1,8(11),15(18),22(25)-tetrakis(4-((diethylmethyl-ammonium)methyl)phenoxy) zinc phthalocyaninate tetraiodide and an asymmetric 4αβZnPc4+ with all four substituents attached to one benzene ring—1,2,3,4-tetrakis(4-((diethylmethyl-ammonium)methyl)phenoxy) zinc phthalocyaninate tetraiodide, synthesized at Frumkin Institute of Physical Chemistry and Electrochemistry [23,33]. Octacationic ZnPcChol8+ zinc octakis(cholinyl)phthalocyanine, developed at the Institute of Organic Intermediates and Dyes (Dolgoprudny, Russia) [22], was used in this study as a comparison compound.
4αZnPc4+ was prepared according to standard procedure by template cyclotetramerization of 3-(4-(diethylaminomethyl)phenoxy)phthalonitrile with zinc acetate in boiling 1-pentanol in the presence of 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU), followed by quaternization in chloroform [24].
4αβZnPc4+ was synthesized by template cyclotetramerization of 1,2,3,4-tetrakis(4-(diethylaminomethyl)phenoxy)phthalonitrile and unsubstituted phthalonitrile with magnesium acetate in boiling 1-pentanol in the presence of DBU. This mixture was then treated with CF3CO2H/H2O in chloroform. This resulted in a mixture of free phthalocyanine bases, which were then converted into a mixture of zinc complexes (zinc acetate, N,N-dimethylformamide, 110 °C). 1,2,3,4-tetrakis(4-(diethylaminomethyl)phenoxy)zinc phthalocyaninate was isolated by size-exclusion chromatography on Bio-Beads SX-1 and quaternized in chloroform, yielding the target 1,2,3,4-tetrakis(4-(diethylammoniumomethyl)phenoxy)zinc phthalocyaninate tetraiodide [23].
Spectral data for these complexes (1H-NMR and UV-Vis) are given in Supporting Information (Table S1).
Stock solutions (10 mM) of 4αZnPc4+ and 4αβZnPc4+ were prepared in dimethyl sulfoxide (DMSO) and subsequently transferred to phosphate-buffered saline (PBS), which was diluted tenfold with distilled water (pH 7.4) to obtain a phthalocyanine concentration of 100 μM in the presence of 1% DMSO. These solutions were used for further experiments. Water-soluble ZnPcChol8+ was prepared directly in PBS, diluted tenfold with distilled water (pH 7.4).

3.2. Fluorescence

The shape of the fluorescence spectra and the fluorescence intensity of polycationic phthalocyanines were studied using the LESA-01-BIOSPEC spectrometer (Biospec, Moscow, Russia) under excitation by a 633 nm laser. The data were analyzed with UnoMomento software v.2.1.3 (Biospec, Moscow, Russia). In order to enhance the luminescence of aryloxy-substituted phthalocyanines in solutions in these experiments, 10% (v/v) FBS was added.
In order to estimate the fluorescence lifetime, phthalocyanines were excited by picosecond laser pulses with a wavelength of 637 nm, and the fluorescence was recorded using a spectroscopic complex with a streak camera (Hamamatsu Photonics, Hamamatsu, Japan).

3.3. Biosensor Escherichia coli

A genetically engineered strain of Gram-negative bacteria E. coli K12 TG1 (luxABCDE) was used as a biosensor [32,33]. Prior to the experiment, the bacterial culture (about 3 × 107 CFU/mL) was suspended in PBS buffer (pH 7.4), diluted tenfold with distilled water PBS/10 (pH 7.4), with the addition of 10 μM CaCl2, and maintained for 1 h at 20–22 °C to achieve stable bioluminescence. Photodynamic inactivation (PDI) was assessed by the decrease in the bioluminescence intensity of a bacterial cell suspension (2 mL) irradiated after 10 min of preincubation at 20–22 °C in the absence of illumination with one of the phthalocyanines, compared with the bioluminescence intensity of cells irradiated with the same dose of light but without adding a photosensitizer. Bioluminescence quenching was expressed via ((B0 − B)/B0), where B0 is the bioluminescence intensity of cells irradiated with red light in the absence of dye, and B is the bioluminescence intensity of cells irradiated in the presence of dyes. The intensity of bioluminescence was measured using a Sirius Smart Line TL luminometer (Berthold GmbH & Co., Bad Wildbad, Germany). The inaccuracy of the method does not exceed 10%.

3.4. Fluorescence Microscopy of Biosensor E. coli with the Studied Photosensitizers

Fluorescence microscopy images were obtained using a Zeiss laser scanning confocal microscope LSM-710 (Carl Zeiss AG, Oberkochen, Germany) under laser excitation at 633 nm, both in a single-channel mode and with spectral resolution. Bacterial suspensions (about 108 CFU/mL) were prepared similarly to those used for photosensitization. Following the addition of one of the phthalocyanines at a final concentration of 5 μM, the bacterial suspension was incubated in the dark at room temperature for 10 min.

3.5. Zeta Potential

The surface charge of E. coli K12 TG1 (luxABCDE) cells was assessed based on the zeta potential values measured using a Zetasizer Nano ZS analyzer (Malvern Instruments, Worcestershire, UK). The zeta potential of bacterial suspensions was measured using methods analogous to those described previously for bioluminescent measurements. The electrostatic binding of phthalocyanines to bacterial cells was determined by neutralizing the negative zeta potential, that is, a shift in the zeta potential values towards more electroneutral values.
All experiments on bioluminescence and zeta potential were performed in triplicate. The measurement of fluorescence intensity was conducted for a minimum of five bacterial samples. The figures show individual fluorescence spectra and, in the case of bioluminescence and zeta potential parameters, averaged data with standard deviations.

4. Conclusions

The obtained results allow us to conclude that the studied tetracationic aryloxy-substituted Zn(II) phthalocyanines effectively bind to the oppositely charged cell wall of Gram-negative bacteria E. coli. It is confirmed by both the results of the cell’s zeta potential neutralization in the presence of phthalocyanine derivatives and fluorescence microscopy images. It has been demonstrated that the binding of phthalocyanine results in a contrast of the emission of the stained bacterial cells compared to that of the solution. The aggregation of phthalocyanine molecules in a water medium, which is more pronounced in the case of an asymmetrically substituted derivative, has little effect on the photodynamic properties of the studied tetracationic phthalocyanines. Both symmetric and asymmetric aryloxy-substituted phthalocyanines demonstrated high activity in the bacterial bioluminescence assay and have significant potential for further studies as antibacterial photosensitizers.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms26199414/s1.

Author Contributions

Conceptualization, G.M., Y.G. and M.S. (Marina Strakhovskaya); methodology, G.M., V.L. (Vladimir Levkin), S.K., I.R., M.S. (Maria Stepanova) and M.S. (Marina Strakhovskaya); software, I.R.; investigation, G.M., E.A., I.R. and M.S. (Marina Strakhovskaya); resources, A.M., V.L. (Victor Loschenov) and M.S. (Marina Strakhovskaya); data curation, G.M. and Y.G.; writing—original draft preparation, all authors; writing—review and editing, all authors; visualization, D.B., E.A. and I.R.; supervision, V.L. (Victor Loschenov); funding acquisition, G.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by RSF, grant number 24-45-00020.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Acknowledgments

The authors thank Zhi-Long Chen and Yan Yi-Jia (Huadong Hospital, Fudan University, Shanghai) for valuable advice in developing the study concept.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Niño-Vega, G.A.; Ortiz-Ramírez, J.A.; López-Romero, E. Novel Antibacterial Approaches and Therapeutic Strategies. Antibiotics 2025, 14, 404. [Google Scholar] [CrossRef]
  2. Tang, K.W.K.; Millar, B.C.; Moore, J.E. Antimicrobial Resistance (AMR). Br. J. Biomed. Sci. 2023, 80, 2023. [Google Scholar] [CrossRef]
  3. MacDermott-Opeskin, H.I.; Gupta, V.; O’Mara, M.L. Lipid-Mediated Antimicrobial Resistance: A Phantom Menace or a New Hope? Biophys. Rev. 2022, 14, 145–162. [Google Scholar] [CrossRef]
  4. Sun, J.; Rutherford, S.T.; Silhavy, T.J.; Huang, K.C. Physical Properties of the Bacterial Outer Membrane. Nat. Rev. Microbiol. 2022, 20, 236–248. [Google Scholar] [CrossRef]
  5. Silipo, A. Lipid A Structure. In Bacterial Lipopolysaccharides; Springer: Vienna, Austria, 2011; pp. 1–20. [Google Scholar]
  6. Brüssow, H. The Antibiotic Resistance Crisis and the Development of New Antibiotics. Microb. Biotechnol. 2024, 17, e14510. [Google Scholar] [CrossRef]
  7. Lang, M.; Carvalho, A.; Baharoglu, Z.; Mazel, D. Aminoglycoside uptake, stress, and potentiation in Gram-negative bacteria: New therapies with old molecules. Microbiol. Mol. Biol. Rev. 2023, 87, e0003622. [Google Scholar] [CrossRef]
  8. Ude, J.; Tripathi, V.; Buyck, J.M.; Söderholm, S.; Cunrath, O.; Fanous, J.; Claudi, B.; Egli, A.; Schleberger, C.; Hiller, S.; et al. Outer Membrane Permeability: Antimicrobials and Diverse Nutrients Bypass Porins in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 2021, 118, e2107644118. [Google Scholar] [CrossRef] [PubMed]
  9. Kholina, E.G.; Kovalenko, I.B.; Strakhovskaya, M.G. Investigation of Porin-Dependent Translocation of Methylene Blue and Gentamicin through the Outer Membrane of Gram-Negative Bacteria Using Molecular Dynamics Methods. Mathematical Biol. Bioinform. 2025, 20, 71–82. [Google Scholar] [CrossRef]
  10. Wainwright, M.; Maisch, T.; Nonell, S.; Plaetzer, K.; Almeida, A.; Tegos, G.P.; Hamblin, M.R. Photoantimicrobials—Are We Afraid of the Light? Lancet Infect. Dis. 2017, 17, e49–e55. [Google Scholar] [CrossRef] [PubMed]
  11. Li, X.; Zheng, B.-D.; Peng, X.-H.; Li, S.-Z.; Ying, J.-W.; Zhao, Y.; Huang, J.-D.; Yoon, J. Phthalocyanines as Medicinal Photosensitizers: Developments in the Last Five Years. Coord. Chem. Rev. 2019, 379, 147–160. [Google Scholar] [CrossRef]
  12. Kollar, J.; Machacek, M.; Halaskova, M.; Lenco, J.; Kucera, R.; Demuth, J.; Rohlickova, M.; Hasonova, K.; Miletin, M.; Novakova, V.; et al. Cationic Versus Anionic Phthalocyanines for Photodynamic Therapy: What a Difference the Charge Makes. J. Med. Chem. 2020, 63, 7616–7632. [Google Scholar] [CrossRef]
  13. Mantareva, V. Phthalocyanine Photosensitizers Towards Drug-Resistant Pathogens; BP International: Kowloon, Hong Kong, 2025; ISBN 978-93-499-7020-5. [Google Scholar]
  14. Pereira, G.F.M.; Tasso, T.T. From cuvette to cells: How the central metal ion modulates the properties of phthalocyanines and porphyrazines as photosensitizers. Inorg. Chim. Acta 2021, 519, 120271. [Google Scholar] [CrossRef]
  15. Gorman, A.; Killoran, J.; O’Shea, C.; Kenna, T.; Gallagher, W.M.; O’Shea, D.F. In Vitro Demonstration of the Heavy-Atom Effect for Photodynamic Therapy. J. Am. Chem. Soc. 2004, 126, 10619–10631. [Google Scholar] [CrossRef] [PubMed]
  16. Amemori, S.; Sasaki, Y.; Yanai, N.; Kimizuka, N. Near-infrared-to-visible photon upconversion sensitized by a metal complex with spin-forbidden yet strong S0–T1 absorption. J. Am. Chem. Soc. 2016, 138, 8702–8705. [Google Scholar] [CrossRef] [PubMed]
  17. Strakhovskaya, M.G.; Antonenko, Y.N.; Pashkovskaya, A.A.; Kotova, E.A.; Kireev, V.; Zhukhovitsky, V.G.; Kuznetsova, N.A.; Yuzhakova, O.A.; Negrimovsky, V.M.; Rubin, A.B. Electrostatic binding of substituted metal phthalocyanines to enterobacterial cells: Its role in photodynamic inactivation. Biochem. Mosc. 2009, 74, 1305–1314. [Google Scholar] [CrossRef]
  18. Muehler, D.; Brandl, E.; Hiller, K.-A.; Cieplik, F.; Maisch, T. Membrane Damage as Mechanism of Photodynamic Inactivation Using Methylene Blue and TMPyP in Escherichia Coli and Staphylococcus Aureus. Photochem. Photobiol. Sci. 2022, 21, 209–220. [Google Scholar] [CrossRef]
  19. Anandan, A.; Vrielink, A. Structure and function of lipid A-modifying enzymes. Ann. N. Y. Acad. Sci. 2020, 1459, 19–37. [Google Scholar] [CrossRef]
  20. Kelbauskas, L.; Dietel, W. Internalization of Aggregated Photosensitizers by Tumor Cells: Subcellular Time-Resolved Fluorescence Spectroscopy on Derivatives of Pyropheophorbide-a Ethers and Chlorin E6 under Femtosecond One- and Two-Photon Excitation. Photochem. Photobiol. 2002, 76, 686. [Google Scholar] [CrossRef]
  21. Halaskova, M.; Kostelansky, F.; Demuth, J.; Hlbocanova, I.; Miletin, M.; Zimcik, P.; Machacek, M.; Novakova, V. Amphiphilic Cationic Phthalocyanines for Photodynamic Therapy of Cancer. ChemPlusChem 2022, 87, e202200133. [Google Scholar] [CrossRef] [PubMed]
  22. Makarov, D.A.; Yuzhakova, O.A.; Slivka, L.K.; Kuznetsova, N.A.; Negrimovsky, V.M.; Kaliya, O.L.; Lukyanets, E.A. Cationic Zn and Al Phthalocyanines: Synthesis, Spectroscopy and Photosensitizing Properties. J. Porphyr. Phthaloc 2007, 11, 586–595. [Google Scholar] [CrossRef]
  23. Bunin, D.A.; Akasov, R.A.; Martynov, A.G.; Stepanova, M.P.; Monich, S.V.; Tsivadze, A.Y.u.; Gorbunova, Y.G. Pivotal Role of the Intracellular Microenvironment in the High Photodynamic Activity of Cationic Phthalocyanines. J. Med. Chem. 2025, 68, 658–673. [Google Scholar] [CrossRef]
  24. Bunin, D.A.; Martynov, A.G.; Safonova, E.A.; Tsivadze, A.Y.u.; Gorbunova, Y.G. Robust Route toward Cationic Phthalocyanines through Reductive Amination. Dye. Pigment. 2022, 207, 110768. [Google Scholar] [CrossRef]
  25. Bunin, D.A.; Martynov, A.G.; Gvozdev, D.A.; Gorbunova, Y.G. Phthalocyanine aggregates in the photodynamic therapy: Dogmas, controversies, and future prospects. Biophys. Rev. 2023, 15, 983–998. [Google Scholar] [CrossRef] [PubMed]
  26. Gallardo-Villagrán, M.; Paulus, L.; Leger, D.Y.; Therrien, B.; Liagre, B. Dimethyl Sulfoxide: A Bio-Friendly or Bio-Hazard Chemical? The Effect of DMSO in Human Fibroblast-like Synoviocytes. Molecules 2022, 27, 4472. [Google Scholar] [CrossRef] [PubMed]
  27. Meerovich, G.A.; Romanishkin, I.D.; Akhlyustina, E.V.; Loschenov, V.B. On the Dependence of Fluorescence Intensity on the Concentration of Photosensitizer Solutions. Biomed. Photonics 2025, 14, 21–26. [Google Scholar] [CrossRef]
  28. Ekineker, G.; Göksel, M. Synthesis of both peripheral and non-peripheral substituted metal-free phthalocyanines and characterization. Tetrahedron 2020, 76, 130878. [Google Scholar] [CrossRef]
  29. Liu, D.; Li, L.; Chen, J.; Chen, Z.; Jiang, L.; Yuan, C.; Huang, M. Dissociation of zinc phthalocyanine aggregation on bacterial surface is key for photodynamic antimicrobial effect. J. Porphyr. Phthalocyanines 2018, 22, 925–934. [Google Scholar] [CrossRef]
  30. Meerovich, G.A.; Akhlyustina, E.V.; Romanishkin, I.D.; Makarova, E.A.; Tiganova, I.G.; Zhukhovitsky, V.G.; Kholina, E.G.; Kovalenko, I.B.; Romanova, Y.M.; Loschenov, V.B.; et al. Photodynamic Inactivation of Bacteria: Why It Is Not Enough to Excite a Photosensitizer. Photodiagnosis Photodyn. Ther. 2023, 44, 103853. [Google Scholar] [CrossRef]
  31. Sakalauskienė, G.V.; Malcienė, L.; Stankevičius, E.; Radzevičienė, A. Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens. Antibiotics 2025, 14, 63. [Google Scholar] [CrossRef]
  32. Strakhovskaya, M.G.; Zarubina, A.; Zhukhovitskii, V.G.; Mironov, A.F.; Rubin, A.B. Bioluminescent genetically transformed bacteria as a new effective tool for testing photosensitization activity. Dokl. Biochem. Biophys. 2004, 396, 177–180. [Google Scholar] [CrossRef]
  33. Strakhovskaya, M.G.; Parkhomenko, I.M.; Rumbal’, Y.V.; Zarubina, A.P.; Danilov, V.S.; Stranadko, E.F. Photoquenching of the Bioluminescence of the Genetically Engineered Escherichia Coli TG1 (pXen7) Strain in the Presence of Photodithazine. Microbiology 2002, 71, 294–297. [Google Scholar] [CrossRef]
  34. Rapacka-Zdończyk, A.; Woźniak, A.; Michalska, K.; Pierański, M.; Ogonowska, P.; Grinholc, M.; Nakonieczna, J. Factors Determining the Susceptibility of Bacteria to Antibacterial Photodynamic Inactivation. Front. Med. 2021, 8, 64260. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Structures of the phthalocyanine derivatives used in this study.
Figure 1. Structures of the phthalocyanine derivatives used in this study.
Ijms 26 09414 g001
Figure 2. Spectral shape of normalized fluorescence spectrum of (A) 4αZnPc4+ and (B) 4αβZnPc4+ in PBS with 10% v/v FBS.
Figure 2. Spectral shape of normalized fluorescence spectrum of (A) 4αZnPc4+ and (B) 4αβZnPc4+ in PBS with 10% v/v FBS.
Ijms 26 09414 g002
Figure 3. Fluorescence lifetimes distribution of (A) 4αZnPc4+, (B) 4αβZnPc4+, and (C) ZnPcChol8+ solutions in PBS or in PBS with FBS 10% (v/v) obtained using Maximum Entropy Method. Resolvable peaks were considered as individual components of the fluorescence decay. The concentration of phthalocyanines was 10 μM, except for 4αβZnPc4+ in PBS, where it was increased to 100 μM.
Figure 3. Fluorescence lifetimes distribution of (A) 4αZnPc4+, (B) 4αβZnPc4+, and (C) ZnPcChol8+ solutions in PBS or in PBS with FBS 10% (v/v) obtained using Maximum Entropy Method. Resolvable peaks were considered as individual components of the fluorescence decay. The concentration of phthalocyanines was 10 μM, except for 4αβZnPc4+ in PBS, where it was increased to 100 μM.
Ijms 26 09414 g003
Figure 4. Normalized fluorescence spectra (AC) and fluorescence spectra (DF) of 4αZnPc4+ (A,D), 4αβZnPc4+ (B,E), and ZnPcChol8+ (C,F) in bacterial sediment and supernatant medium (PBS) after addition of phthalocyanine derivatives (5 µM).
Figure 4. Normalized fluorescence spectra (AC) and fluorescence spectra (DF) of 4αZnPc4+ (A,D), 4αβZnPc4+ (B,E), and ZnPcChol8+ (C,F) in bacterial sediment and supernatant medium (PBS) after addition of phthalocyanine derivatives (5 µM).
Ijms 26 09414 g004
Figure 5. Averaged normalized fluorescence spectra of (A) 4αZnPc4+, (B) 4αβZnPc4+, and (C) ZnPcChol8+, bound to bacteria (N = 5), obtained using Zeiss laser scanning confocal microscope LSM-710 under laser excitation at 633 nm.
Figure 5. Averaged normalized fluorescence spectra of (A) 4αZnPc4+, (B) 4αβZnPc4+, and (C) ZnPcChol8+, bound to bacteria (N = 5), obtained using Zeiss laser scanning confocal microscope LSM-710 under laser excitation at 633 nm.
Ijms 26 09414 g005
Figure 6. Bioluminescence of E. coli K12 TG1 (luxABCDE) after 10 min incubation with the studied photosensitizers at (A) 1 μM and (B) 2 μM concentration, and further irradiation with red light-emitting diode (LED) 686 nm.
Figure 6. Bioluminescence of E. coli K12 TG1 (luxABCDE) after 10 min incubation with the studied photosensitizers at (A) 1 μM and (B) 2 μM concentration, and further irradiation with red light-emitting diode (LED) 686 nm.
Ijms 26 09414 g006
Table 1. Ratio between the mean fluorescence of bacteria (N = 5) and the mean fluorescence of the surrounding solution after 10 min incubation with 5 µM of different phthalocyanine derivatives obtained using a scanning confocal microscope.
Table 1. Ratio between the mean fluorescence of bacteria (N = 5) and the mean fluorescence of the surrounding solution after 10 min incubation with 5 µM of different phthalocyanine derivatives obtained using a scanning confocal microscope.
N4αZnPc4+4αβZnPc4+ZnPcChol8+
14.387.235.08
23.126.011.63
35.056.422.51
43.5713.065.20
51.907.258.14
Table 2. The zeta potential of E. coli K12 TG1 biosensor cells. Initial value without incubation with 4αZnPc4+, 4αβZnPc4+, and ZnPcChol8+ was −37.0 (±3.8) mV. The deviation of the zeta potential is indicated in brackets.
Table 2. The zeta potential of E. coli K12 TG1 biosensor cells. Initial value without incubation with 4αZnPc4+, 4αβZnPc4+, and ZnPcChol8+ was −37.0 (±3.8) mV. The deviation of the zeta potential is indicated in brackets.
Phthalocyanines (Pcs)Pcs Concentration, 1 µMPcs Concentration, 2 µM
4αZnPc4+−28.6 (±6.8)−12.7 (±5.4)
4αβZnPc4+−25.7 (±4.9)−19.8 (±7.8)
ZnPcChol8+−24.8 (±5.7)−15.7 (±6.1)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Meerovich, G.; Bunin, D.; Akhlyustina, E.; Romanishkin, I.; Levkin, V.; Kharnas, S.; Stepanova, M.; Martynov, A.; Loschenov, V.; Gorbunova, Y.; et al. The Photodynamic Antibacterial Potential of New Tetracationic Zinc(II) Phthalocyanines Bearing 4-((Diethylmethylammonium)methyl)phenoxy Substituents. Int. J. Mol. Sci. 2025, 26, 9414. https://doi.org/10.3390/ijms26199414

AMA Style

Meerovich G, Bunin D, Akhlyustina E, Romanishkin I, Levkin V, Kharnas S, Stepanova M, Martynov A, Loschenov V, Gorbunova Y, et al. The Photodynamic Antibacterial Potential of New Tetracationic Zinc(II) Phthalocyanines Bearing 4-((Diethylmethylammonium)methyl)phenoxy Substituents. International Journal of Molecular Sciences. 2025; 26(19):9414. https://doi.org/10.3390/ijms26199414

Chicago/Turabian Style

Meerovich, Gennady, Dmitry Bunin, Ekaterina Akhlyustina, Igor Romanishkin, Vladimir Levkin, Sergey Kharnas, Maria Stepanova, Alexander Martynov, Victor Loschenov, Yulia Gorbunova, and et al. 2025. "The Photodynamic Antibacterial Potential of New Tetracationic Zinc(II) Phthalocyanines Bearing 4-((Diethylmethylammonium)methyl)phenoxy Substituents" International Journal of Molecular Sciences 26, no. 19: 9414. https://doi.org/10.3390/ijms26199414

APA Style

Meerovich, G., Bunin, D., Akhlyustina, E., Romanishkin, I., Levkin, V., Kharnas, S., Stepanova, M., Martynov, A., Loschenov, V., Gorbunova, Y., & Strakhovskaya, M. (2025). The Photodynamic Antibacterial Potential of New Tetracationic Zinc(II) Phthalocyanines Bearing 4-((Diethylmethylammonium)methyl)phenoxy Substituents. International Journal of Molecular Sciences, 26(19), 9414. https://doi.org/10.3390/ijms26199414

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop